NCT Number: NCT00184652
Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–99 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Novo Nordisk Investigational Site, København Ø, Denmark
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- ESRD patients
Exclusion criteria
- Diabetes Mellitus
- Severe and Malignant diseases
- Patients in Intensive Care Units
Treatment and study plan
Primary outcomes
-
Change in surrogate markers of nutrition
Time frame: After 6 months treatment
Secondary outcomes
-
Quality of Life
-
Other markers of nutrition
Sponsors and collaborators
Lead sponsor
Novo Nordisk A/S
Industry
Registry information
Official study title
The Effect of Norditropin® on Nutritional Status in Adult Patients in Chronic Haemodialysis
Important dates
- Study start
- 2003
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Sep 16, 2005
- Registry last updated
- Jan 24, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
House Calls and Peer Mentorship
NCT03354910
Chronic Disease, Chronic Kidney Disease
Boston, Massachusetts, United States
View Trial DetailsHealth Outcomes Patient Education
NCT02976220
Chronic Disease, Chronic Kidney Disease
San Francisco, California, United States
View Trial DetailsHouse Calls and Decision Support: Improving Access to Live Donor Transplantation
NCT01786525
Chronic Disease, Chronic Kidney Disease
Boston, Massachusetts, United States
View Trial DetailsA Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation
NCT00785265
Chronic Disease, Chronic Kidney Disease
Boston, Massachusetts, United States
View Trial Details